Conny K. Baldauf

Leipziger Str. 44
Magdeburg, ST 39120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Integrin-dependence of extramedullary erythropoiesis in the spleen of Jak2-V617F positive myeloproliferative neoplasm in mice.

Integrin-dependence of extramedullary erythropoiesis in the spleen of Jak2-V617F positive myeloproliferative neoplasm in mice.

Journal: Experimental hematology

Published: April 29, 2025

Activation of integrin signaling up-regulates pro-inflammatory cytokines in JAK2-V617F positive hematopoietic cells.

Activation of integrin signaling up-regulates pro-inflammatory cytokines in JAK2-V617F positive hematopoietic cells.

Journal: Cell communication and signaling : CCS

Published: April 16, 2025

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.

Journal: Journal of hematology & oncology

Published: March 22, 2024

NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.

NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.

Journal: Nature communications

Published: March 14, 2024

Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.

Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.

Journal: Cell communication and signaling : CCS

Published: December 05, 2023

Thromboinflammation in Myeloproliferative Neoplasms (MPN)-A Puzzle Still to Be Solved.

Thromboinflammation in Myeloproliferative Neoplasms (MPN)-A Puzzle Still to Be Solved.

Journal: International journal of molecular sciences

Published: February 16, 2022

Genetic Knock-out of TNFR1 and TNFR2 in a JAK2-V617F Polycythemia Vera Mouse Model.

Genetic Knock-out of TNFR1 and TNFR2 in a JAK2-V617F Polycythemia Vera Mouse Model.

Journal: HemaSphere

Published: November 29, 2021

Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease.

Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease.

Journal: Blood advances

Published: February 04, 2021

Anti-IL-6 cytokine treatment has no impact on elevated hematocrit or splenomegaly in a polycythemia vera mouse model.

Anti-IL-6 cytokine treatment has no impact on elevated hematocrit or splenomegaly in a polycythemia vera mouse model.

Journal: Blood advances

Published: January 28, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026